Angela McDonald, PA
Physician Assistant · Thornton, CONPI 1972735488
Payments from drug & device makers
Across 406 payments — averaging $19.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$1K
- AstraZeneca$1K
- GSK$1K
- Takeda Pharmaceuticals U.S.A., Inc.$708
- Sanofi$482
- CSL Behring$296
- plus $3K from 32 others
What the payments were for
- Consulting fees$731%
- Food & beverage$7,76096%
- Education$2123%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 78 | $1,381 |
| AstraZeneca | 60 | $1,323 |
| GSK | 60 | $1,167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $708 |
| Sanofi | 26 | $482 |
| CSL Behring | 16 | $296 |
| Novartis | 14 | $258 |
| Kaleo, Inc. | 10 | $217 |
| Lilly USA, LLC | 11 | $204 |
| AbbVie | 11 | $195 |
| Biocryst US Sales Co., LLC | 9 | $179 |
| Pharming Healthcare, Inc. | 11 | $175 |
| Genentech USA, Inc. | 8 | $174 |
| Teva Pharmaceuticals USA, Inc. | 7 | $130 |
| Nestle Healthcare Nutrition Inc. | 7 | $124 |
| Grifols USA, LLC | 5 | $98 |
| Ionis Pharmaceuticals, Inc. | 3 | $91 |
| ADMA Biomanufacturing LLC | 3 | $89 |
| Cycle Pharmaceuticals Inc | 4 | $87 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $87 |
| Amgen | 4 | $85 |
| Pfizer | 3 | $51 |
| Aimmune Therapeutics, Inc. | 3 | $48 |
| Seqirus USA Inc | 2 | $45 |
| Electromed, Inc. | 2 | $43 |
| Jazz Pharmaceuticals Inc. | 2 | $42 |
| LEO Pharma Inc. | 2 | $41 |
| Optinose US, Inc. | 2 | $31 |
| Kedrion Biopharma, Inc. | 1 | $29 |
| Aerin Medical Inc. | 1 | $25 |
| Octapharma USA, Inc. | 1 | $22 |
| X4 Pharmaceuticals, Inc. | 1 | $22 |
| Novo Nordisk | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| GC Biopharma USA, Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Organon | 1 | $12 |
How this compares
$8,046 in reported general payments places this provider in the 95th percentile of 2,849 physician assistant providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RuconestC1 Esterase Inhibitor, Recomb | 20 | $2,173,688 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 17 | $99,715 |
| XolairOmalizumab | 26 | $94,572 |
| Dupixent SyringeDupilumab | 20 | $77,890 |
| SymbicortBudesonide/Formoterol Fumarate | 27 | $8,109 |
| Cromolyn Sodium | 17 | $4,515 |
| Qvar RedihalerBeclomethasone Dipropionate | 11 | $3,265 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $1,471 |
| Ventolin HfaAlbuterol Sulfate | 24 | $1,312 |
| SynthroidLevothyroxine Sodium | 15 | $1,018 |
| Famotidine | 24 | $601 |
| Montelukast Sodium | 38 | $332 |
| Levocetirizine Dihydrochloride | 16 | $177 |
| Dexamethasone | 11 | $60 |
| Azithromycin | 17 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Pharming Healthcare, Inc.Ruconest | $175 | $2,173,68820 claims |
| CSL BehringPrivigen | $296 | $99,71517 claims |
| AstraZenecaSymbicort | $1,323 | $8,10927 claims |
| Cycle Pharmaceuticals IncCromolyn Sodium | $87 | $4,51517 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $130 | $3,26511 claims |
| AbbVieSynthroid | $195 | $1,01815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,849 physician assistant providers in Colorado.
Other physician assistant in Thornton
- Ashley HyattThornton$14K
- Donald MooreEnglewood$246K
- Neekan AeiniGreenwood Village$234K
- Korby HowellCortez$182K
- Heather FinlaysonLittleton$180K
- Kristen LervikDenver$131K
- Marissa Moritz-GuzikLouisville$94K
- Clayton LabaumeDurango$87K
- Emily FrischDenver$79K
- Daniel HumerLone Tree$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.